494 related articles for article (PubMed ID: 16801132)
21. Dopamine-dependent ectodomain shedding and release of epidermal growth factor in developing striatum: target-derived neurotrophic signaling (Part 2).
Iwakura Y; Wang R; Abe Y; Piao YS; Shishido Y; Higashiyama S; Takei N; Nawa H
J Neurochem; 2011 Jul; 118(1):57-68. PubMed ID: 21534959
[TBL] [Abstract][Full Text] [Related]
22. Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage.
Sweeney C; Carraway KL
Oncogene; 2000 Nov; 19(49):5568-73. PubMed ID: 11114736
[TBL] [Abstract][Full Text] [Related]
23. Neuregulin growth factors and their ErbB receptors form a potential signaling network for schwannoma tumorigenesis.
Stonecypher MS; Chaudhury AR; Byer SJ; Carroll SL
J Neuropathol Exp Neurol; 2006 Feb; 65(2):162-75. PubMed ID: 16462207
[TBL] [Abstract][Full Text] [Related]
24. The chemical synthesis and binding affinity to the EGF receptor of the EGF-like domain of heparin-binding EGF-like growth factor (HB-EGF).
Shin SY; Yokoyama T; Takenouchi T; Munekata E
J Pept Sci; 2003 Apr; 9(4):244-50. PubMed ID: 12725245
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3.
Wingens M; Jacobs-Oomen S; van der Woning SP; Stortelers C; van Zoelen EJ
Biochemistry; 2006 Apr; 45(14):4703-10. PubMed ID: 16584205
[TBL] [Abstract][Full Text] [Related]
26. EGF-receptor-mediated mammary epithelial cell migration is driven by sustained ERK signaling from autocrine stimulation.
Joslin EJ; Opresko LK; Wells A; Wiley HS; Lauffenburger DA
J Cell Sci; 2007 Oct; 120(Pt 20):3688-99. PubMed ID: 17895366
[TBL] [Abstract][Full Text] [Related]
27. A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity.
Goldoni S; Iozzo RA; Kay P; Campbell S; McQuillan A; Agnew C; Zhu JX; Keene DR; Reed CC; Iozzo RV
Oncogene; 2007 Jan; 26(3):368-81. PubMed ID: 16847455
[TBL] [Abstract][Full Text] [Related]
28. Ectodomain shedding and remnant peptide signalling of EGFRs and their ligands.
Higashiyama S; Nanba D; Nakayama H; Inoue H; Fukuda S
J Biochem; 2011 Jul; 150(1):15-22. PubMed ID: 21610047
[TBL] [Abstract][Full Text] [Related]
29. Identification of serum factor inducing ectodomain shedding of proHB-EGF and sStudies of noncleavable mutants of proHB-EGF.
Hirata M; Umata T; Takahashi T; Ohnuma M; Miura Y; Iwamoto R; Mekada E
Biochem Biophys Res Commun; 2001 May; 283(4):915-22. PubMed ID: 11350072
[TBL] [Abstract][Full Text] [Related]
30. Nuclear envelope-localized EGF family protein amphiregulin activates breast cancer cell migration in an EGF-like domain independent manner.
Tanaka H; Nishioka Y; Yokoyama Y; Higashiyama S; Matsuura N; Matsuura S; Hieda M
Biochem Biophys Res Commun; 2012 Apr; 420(4):721-6. PubMed ID: 22445895
[TBL] [Abstract][Full Text] [Related]
31. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
[TBL] [Abstract][Full Text] [Related]
32. Spatiotemporal visualization of proHB-EGF ectodomain shedding in living cells.
Inoue H; Sakaue T; Ozawa T; Higashiyama S
J Biochem; 2013 Jul; 154(1):67-76. PubMed ID: 23598347
[TBL] [Abstract][Full Text] [Related]
33. G-protein-coupled receptor signaling and the EGF network in endocrine systems.
Hsieh M; Conti M
Trends Endocrinol Metab; 2005 Sep; 16(7):320-6. PubMed ID: 16054836
[TBL] [Abstract][Full Text] [Related]
34. Signal transduction and oncogenesis by ErbB/HER receptors.
Marmor MD; Skaria KB; Yarden Y
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):903-13. PubMed ID: 14967450
[TBL] [Abstract][Full Text] [Related]
35. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells.
Tao RH; Maruyama IN
J Cell Sci; 2008 Oct; 121(Pt 19):3207-17. PubMed ID: 18782861
[TBL] [Abstract][Full Text] [Related]
36. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk.
Higashiyama S; Nanba D
Biochim Biophys Acta; 2005 Aug; 1751(1):110-7. PubMed ID: 16054021
[TBL] [Abstract][Full Text] [Related]
37. A diphtheria toxin receptor deficient in epidermal growth factor-like biological activity.
Furukawa N; Saito M; Hakoshima T; Kohno K
J Biochem; 2006 Dec; 140(6):831-41. PubMed ID: 17071947
[TBL] [Abstract][Full Text] [Related]
38. Structure of the extracellular region of HER3 reveals an interdomain tether.
Cho HS; Leahy DJ
Science; 2002 Aug; 297(5585):1330-3. PubMed ID: 12154198
[TBL] [Abstract][Full Text] [Related]
39. The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies.
Dougall WC; Qian X; Peterson NC; Miller MJ; Samanta A; Greene MI
Oncogene; 1994 Aug; 9(8):2109-23. PubMed ID: 7913542
[TBL] [Abstract][Full Text] [Related]
40. The bioactivity and receptor affinity of recombinant tagged EGF designed for tissue engineering applications is defined by the nature and position of the tags.
Boucher C; St-Laurent G; Loignon M; Jolicoeur M; De Crescenzo G; Durocher Y
Tissue Eng Part A; 2008 Dec; 14(12):2069-77. PubMed ID: 18652537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
